Nanotechnology Now

Our NanoNews Digest Sponsors


Heifer International

Wikipedia Affiliate Button


DHgate

Home > Press > NanoBusiness Alliance Announces Participation in Livingston Healthcare & Life Sciences Summit, Debuting in NYC September 10th With Focus on “Capturin

Abstract:
The NanoBusiness Alliance today announced that Vice President Vincent Caprio will be participating in the debut of The Livingston Healthcare & Life Science Stakeholders Summit - "Capturing Trends and Global Outlook: Advanced and Nano Technologies," being held on September 10, 2008 at the Renaissance Hotel Times Square in New York City.

NanoBusiness Alliance Announces Participation in Livingston Healthcare & Life Sciences Summit, Debuting in NYC September 10th With Focus on “Capturin

New York, NY | Posted on August 27th, 2008

"Over the past three years, the Axiom Capital Management/Livingston Nanotechnology Conference has emerged as an important gathering for the investment community and pioneers in the area of nanotechnology," said Vincent Caprio, Vice President and Event Director, NanoBusiness Alliance. "I'm excited to be presenting at Scott Livingston's new event, with a focus on the tremendous opportunities for nanotechnology in the field of healthcare and life science."

The summit is a unique and by invitation-only conference designed around three important global issues for investors:

* Drug Discovery and Development: Early to Mid-Stage
* Diagnostics: Valuation and Future Directions
* Global and Emerging Investment Opportunities

Invitees include CEOs, CFOs, COOs for a broad range of pharmaceutical, diagnostic, and platform technology companies, a select number of US and International VCs and PEs, along with key policy makers and federal science and regulatory agencies.

"Our Healthcare & Life Sciences Summit has been designed to bring together key stakeholders from pharmaceutical, capital investment, business strategy and federal science and regulatory segments," said Scott Livingston, managing director of Axiom Capital Management, and head of the Livingston Group, a division within Axiom that focuses on nanotechnology. "Due to its exclusive nature, we can assure that in addition to helping attendees identify key trends, the event will provide for significant opportunities among participants for deal making."

For information on registering for the Livingston Healthcare & Life Sciences Summit, please contact Jonathan Mason at .

####

About NanoBusiness Alliance
The NanoBusiness Alliance is the industry association for the emerging nanotechnology industry. Through its extensive network of leading startups, Fortune 500 companies, research institutions, non-governmental organizations and public-private partnerships, the Alliance shapes nanotechnology policy and helps accelerate the commercialization of nanotechnology innovations.

About Axiom Capital Management Inc. and the Livingston Group

Axiom Capital Management Inc. is a FINRA registered broker/dealer that works with growth companies and institutional investors and provides corporate finance, prime brokerage and private equity opportunities to a wide range of customers.

The Livingston Group was formed by Scott Livingston, who joined Axiom Capital Management Inc. in 2005 after a 15-year career on Wall Street, and has been working exclusively on nanotechnology investments since 2002. Scott has been called "sharp and highly connected” by the Forbes Wolfe Nanotechnology Report (July 1, 2005) and has been an invited speaker on nanotechnology investment trends at MIT, the Harvard Club, the Nanobusiness Alliance, the Cambridge Healthtech Institute, Nanotechnology.com, the International Business Forum, Albany Nanotech, the Delaware Technology Park, the Business Executives for National Security, Hillary Clinton's Jobs for New York, WXXA Fox 23, Cold Spring Harbor's Dolan DNA Learning Center and has presented to half a dozen state pension leaders across the country. Scott is also the creator of the annual Axiom Capital Management "Livingston Nanotechnology Conference," one of the best attended nanotechnology forums of the year.

For more information, please click here

Contacts:
Schwartz Public Relations
Steven Wright-Mark
212-677-8700 ext. 29

Copyright © Business Wire 2008

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Personal cooling units on the horizon April 29th, 2016

Exploring phosphorene, a promising new material April 29th, 2016

Arrowhead Pharmaceuticals Files for Regulatory Clearance to Begin Phase 1/2 Study of ARC-521 April 28th, 2016

The Translational Research Center at the University Hospital of Erlangen in Germany uses the ZetaView from Particle Metrix to quantify extracellular vesicles such as exosomes April 28th, 2016

VC/Funding/Angel financing/Loans/Leases/Crowdfunding

ORIG3N Added to Companies Presenting at Harris & Harris Group's Annual Meeting, Tuesday June 7, 2016, the New York Genome Center April 27th, 2016

Philadelphia Mathematician Robert Clark Turns to Crowdfunding to Support Nanotechnology Research That Could Lead to ‘Flying’ Cars and Space Elevator April 4th, 2016

Harris & Harris Group Announces Formation of Co-Investment Fund for Accredited Investors March 9th, 2016

Clinatec Announces €30M Fundraising Campaign to Speed Research In Treatment of Neurodegenerative Diseases, Cancer and Motor Disabilities February 24th, 2016

Investments/IPO's/Splits

ORIG3N Added to Companies Presenting at Harris & Harris Group's Annual Meeting, Tuesday June 7, 2016, the New York Genome Center April 27th, 2016

Aspen Aerogels to Present at the 28th Annual ROTH Conference March 14th, 2016

Harris & Harris Group Announces Formation of Co-Investment Fund for Accredited Investors March 9th, 2016

Arrowhead to Present at Upcoming March Conferences March 1st, 2016

Nanomedicine

Nanoparticles hold promise as double-edged sword against genital herpes April 28th, 2016

Arrowhead Pharmaceuticals Files for Regulatory Clearance to Begin Phase 1/2 Study of ARC-521 April 28th, 2016

The Translational Research Center at the University Hospital of Erlangen in Germany uses the ZetaView from Particle Metrix to quantify extracellular vesicles such as exosomes April 28th, 2016

JPK reports on the use of a NanoWizard AFM system at the University of Kaiserslautern to study the interaction of bacteria with microstructured surfaces April 28th, 2016

Announcements

Personal cooling units on the horizon April 29th, 2016

Exploring phosphorene, a promising new material April 29th, 2016

Arrowhead Pharmaceuticals Files for Regulatory Clearance to Begin Phase 1/2 Study of ARC-521 April 28th, 2016

The Translational Research Center at the University Hospital of Erlangen in Germany uses the ZetaView from Particle Metrix to quantify extracellular vesicles such as exosomes April 28th, 2016

Events/Classes

Researchers create a first frequency comb of time-bin entangled qubits: Discovery is a significant step toward multi-channel quantum communication and higher capacity quantum computers April 28th, 2016

Introducing the RE標ORK Bio-inspired Robotics Summit in Berlin April 27th, 2016

ORIG3N Added to Companies Presenting at Harris & Harris Group's Annual Meeting, Tuesday June 7, 2016, the New York Genome Center April 27th, 2016

Team builds first quantum cascade laser on silicon: Eliminates the need for an external light source for mid-infrared silicon photonic devices or photonic circuits April 21st, 2016

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







Car Brands
Buy website traffic